NRC Health (NRC): Revenue

Annual figures by period end, from SEC filings.

$137.39M
Year ended 2025-12-31
$140.00M
Trailing 12 months to 2026-06-30
-3.2%
3-year compound annual growth
+0.6%
5-year compound annual growth
+3.0%
10-year compound annual growth
$151.57M2009-12-31: $57.69M2010-12-31: $63.40M2011-12-31: $75.77M2012-12-31: $86.42M2013-12-31: $92.59M2014-12-31: $98.84M2015-12-31: $102.34M2016-12-31: $109.38M2017-12-31: $117.56M2018-12-31: $119.69M2019-12-31: $127.98M2020-12-31: $133.28M2021-12-31: $147.95M2022-12-31: $151.57M2023-12-31: $148.58M2024-12-31: $143.06M2025-12-31: $137.39M$137.39M
2009-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$137.39M-4.0%2026-03-05, From 2025-01-01
2024-12-31$143.06M-3.7%2026-03-05, From 2024-01-01
2023-12-31$148.58M-2.0%2026-03-05, From 2023-01-01
2022-12-31$151.57M+2.4%2025-03-17, From 2022-01-01
2021-12-31$147.95M+11.0%2024-02-27, From 2021-01-01
2020-12-31$133.28M+4.1%2023-03-03, From 2020-01-01
2019-12-31$127.98M+6.9%2022-03-04, From 2019-01-01
2018-12-31$119.69M+1.8%2021-03-05, From 2018-01-01
2017-12-31$117.56M+7.5%2020-03-06, From 2017-01-01
2016-12-31$109.38M+6.9%2019-03-08, From 2016-01-01
2015-12-31$102.34M+3.5%2018-03-14, From 2015-01-01
2014-12-31$98.84M+6.7%2017-03-03, From 2014-01-01
2013-12-31$92.59M+7.1%2016-03-04, From 2013-01-01
2012-12-31$86.42M+14.1%2015-03-04, From 2012-01-01
2011-12-31$75.77M+19.5%2014-03-04, From 2011-01-01
2010-12-31$63.40M+9.9%2013-03-01, From 2010-01-01
2009-12-31$57.69Mn/a2012-03-01, From 2009-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
NRC Health (NRC)2025-12-31$137.39M-4.0%
MaxCyte, Inc. (MXCT)2025-12-31$33.03M-14.5%
OmniAb, Inc. (OABI)2025-12-31$18.67M-29.3%
Foxo Technologies Inc. (FOXO)2025-12-31$16.37M+304.0%
Medpace Holdings, Inc. (MEDP)2025-12-31$2.53B+20.0%
bioAffinity Technologies, Inc. (BIAF)2025-12-31$6.16M-34.2%
Charles River Laboratories International, Inc. (CRL)2025-12-27$4.02B-0.9%
Incyte Corp (INCY)2025-12-31$5.14B+21.2%
Absci Corp (ABSI)2025-12-31$2.80M-38.2%

Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗